Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05277051
Status:
RECRUITING
Last Update Posted:
2024-01-11
First Post:
2022-03-03
Brief Title:
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasms |
Keywords:
| Name | View |
|---|---|
| Ovarian epithelial cancer OEC | View |
| Advanced solid tumors | View |
| Metastatic solid tumor | View |
| Anticancer agents | View |
| Dostarlimab | View |
| GSK4381562 | View |
| GSK4428859A | View |
| Head and neck squamous cell carcinoma HNSCC | View |
| Non-small-cell lung cancer NSCLC | View |
| Breast cancer BC | View |
| Clear cell renal cell cancer ccRCC | View |
| Gastric cancer GC | View |
| Colorectal cancer CRC | View |
| Endometrial cancer EC | View |